CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...